Absence of β6 Integrin Reduces Influenza Disease Severity in Highly Susceptible Obese Mice.
Acute Lung Injury
/ immunology
Animals
Disease Models, Animal
Dogs
Gene Knockout Techniques
HEK293 Cells
Humans
Influenza A Virus, H1N1 Subtype
/ immunology
Integrin beta Chains
/ genetics
Interferon Type I
/ metabolism
Madin Darby Canine Kidney Cells
Mice
Mice, Inbred C57BL
Obesity
/ complications
Orthomyxoviridae Infections
/ genetics
Receptor, Interferon alpha-beta
/ metabolism
Signal Transduction
Trauma Severity Indices
influenza
obesity
type I interferon
β6 integrin
Journal
Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724
Informations de publication
Date de publication:
15 01 2019
15 01 2019
Historique:
received:
17
09
2018
accepted:
22
10
2018
pubmed:
2
11
2018
medline:
23
10
2019
entrez:
2
11
2018
Statut:
epublish
Résumé
Obese individuals are considered a high-risk group for developing severe influenza virus infection. While the exact mechanisms for increased disease severity remain under investigation, obese-mouse models suggest that increased acute lung injury (ALI), potentially due to enhanced viral spread and decreased wound repair, is likely involved. We previously demonstrated that upregulation of the lung epithelial cell β6 integrin during influenza virus infection was involved in disease severity. Knocking out β6 (β6 KO) resulted in improved survival. Of interest, obese mice have increased lung β6 integrin levels at homeostasis. Thus, we hypothesized that the protective effect seen in β6 KO mice would extend to the highly susceptible obese-mouse model. In the current study, we show that crossing β6 KO mice with genetically obese (ob/ob) mice (OBKO) resulted in reduced ALI and impaired viral spread, like their lean counterparts. Mechanistically, OBKO alveolar macrophages and epithelial cells had increased type I interferon (IFN) signaling, potentially through upregulated type I IFN receptor expression, which was important for the enhanced protection during infection. Taken together, our results indicate that the absence of an epithelial integrin can beneficially alter the pulmonary microenvironment by increasing protective type I IFN responses even in a highly susceptible obese-mouse model. These studies increase our understanding of influenza virus pathogenesis in high-risk populations and may lead to the development of novel therapies.
Identifiants
pubmed: 30381485
pii: JVI.01646-18
doi: 10.1128/JVI.01646-18
pmc: PMC6321928
pii:
doi:
Substances chimiques
Integrin beta Chains
0
Interferon Type I
0
integrin beta6
0
Receptor, Interferon alpha-beta
156986-95-7
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : HHSN272201400006C
Pays : United States
Informations de copyright
Copyright © 2019 American Society for Microbiology.
Références
Gut. 2018 Jan;67(1):157-165
pubmed: 28011892
J Cell Sci. 1995 Jun;108 ( Pt 6):2241-51
pubmed: 7673344
Immunol Cell Biol. 2007 Feb-Mar;85(2):85-92
pubmed: 17213831
PLoS Pathog. 2016 Aug 09;12(8):e1005804
pubmed: 27505057
Nature. 2003 Mar 13;422(6928):169-73
pubmed: 12634787
Nat Commun. 2015 Mar 06;6:6378
pubmed: 25744559
Nat Rev Cancer. 2002 Feb;2(2):91-100
pubmed: 12635172
J Infect Dis. 2012 Jan 15;205(2):252-61
pubmed: 22147799
Int J Obes (Lond). 2017 Sep;41(9):1324-1330
pubmed: 28584297
J Natl Cancer Inst. 2014 Jun 28;106(8):
pubmed: 24974129
mBio. 2017 Sep 19;8(5):
pubmed: 28928207
Proc Nutr Soc. 2012 May;71(2):298-306
pubmed: 22414338
Oncogene. 2013 Sep 12;32(37):4406-16
pubmed: 23108397
Euro Surveill. 2010 Sep 23;15(38):
pubmed: 20929651
Mol Imaging. 2017 Jan 1;16:1536012117709384
pubmed: 28627323
Immunology. 2009 Feb;126(2):268-79
pubmed: 18754811
Chest. 2011 Feb;139(2):382-386
pubmed: 20688928
Clin Infect Dis. 2011 Sep;53(5):422-4
pubmed: 21844025
Clin Infect Dis. 2011 Feb 1;52(3):301-12
pubmed: 21208911
J Immunol. 2010 Mar 15;184(6):3127-33
pubmed: 20173021
Surg Infect (Larchmt). 2009 Apr;10(2):137-42
pubmed: 19388836
J Virol. 2013 Dec;87(24):13321-9
pubmed: 24089552
Inflammation. 2017 Feb;40(1):58-67
pubmed: 27704310
Nutrition. 2013 Jan;29(1):207-12
pubmed: 22951153
F1000Prime Rep. 2014 Mar 03;6:16
pubmed: 24669297
J Nutr. 2007 May;137(5):1236-43
pubmed: 17449587
PLoS Curr. 2010 Mar 09;2:RRN1150
pubmed: 20228857
J Appl Physiol (1985). 2010 Mar;108(3):722-8
pubmed: 19875709
Cell. 1999 Feb 5;96(3):319-28
pubmed: 10025398
Nat Rev Immunol. 2015 Apr;15(4):231-42
pubmed: 25790790
Science. 1994 Jun 24;264(5167):1918-21
pubmed: 8009221
J Exp Med. 2011 Jan 17;208(1):167-80
pubmed: 21187318
mBio. 2016 Aug 02;7(4):
pubmed: 27486196
Clin Sci (Lond). 2008 Feb;114(4):275-88
pubmed: 18194136
Hum Vaccin Immunother. 2014;10(5):1181-6
pubmed: 24614530
J Virol. 2011 Dec;85(23):12262-70
pubmed: 21917948
PLoS One. 2010 Mar 15;5(3):e9694
pubmed: 20300571